This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

Naver's 'tricky and unprecedented' self-preferencing case wraps up in South Korean court

By Wooyoung Lee ( September 15, 2022, 05:42 GMT | Insight) -- Naver’s long-running court battle with South Korea’s competition regulator over allegations the tech giant engaged in self-preferencing conduct for its online shopping service has entered the home stretch, with both sides wrapping up their arguments in a final hearing on Wednesday. In reviewing a case they described as “tricky and unprecedented,” judges of the Seoul High Court set Dec. 14 as the date for a final verdict — a verdict which is likely to hinge on how the court defines the market in which Naver’s shopping service had been operating.Naver’s long-running court battle with South Korea’s competition regulator over allegations the tech giant engaged in self-preferencing conduct for its online shopping service has entered the home stretch, with both sides wrapping up their arguments in a final hearing on Wednesday....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections